This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The IMA Group strengthens its presence in aseptic and containment isolator technology. IMA has recently signed with ProSys Sampling Systems Limited an agreement that provides for the purchase of a majority of the company’s shares. Established in 1997, ProSys is a leading provider of Isolator and Sampling equipment to the global bio-pharmaceutical market.
Michael McLoughlin co-founded ProSys, headquartered in Cork, Ireland in 1997, building the company over the past 29 years into one of the leading suppliers of Isolator and Sampling equipment technology to the global bio-pharmaceutical market.
Michael McLoughlin will remain on as Managing Director of ProSys, which will continue to work as an independent business, working closely with Michele Arduini, Managing Director of IMA Life.
For ProSys, joining the IMA Group represents an excellent opportunity to support business development and long-term growth. We look forward to contributing our knowledge, in aseptic, containment and sampling technology to the combined portfolio and to becoming part of the IMA team, united by a shared business culture.
